Clopidogrel or apixaban in atrial fibrillation patients unsuitable for vitamin-K antagonists for stroke prevention in atrial fibrillation? Lessons from the recent aspirin-controlled trials

被引：0
|
作者：
Verheugt, F. W. A. [1 ]
Jaspersfocks, J. [2 ]
Brouwer, M. A. [2 ]
机构：
[1] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, NL-6525 ED Nijmegen, Netherlands
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [41] Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation
    Friberg, J
    Gislason, GH
    Gadsboll, N
    Rasmussen, JN
    Rasmussen, S
    Abildstrom, SZ
    Kober, L
    Madsen, M
    Torp-Pedersen, C
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (02) : 173 - 178
  • [42] EFFICACY OF ANTICOAGULATION WITH VITAMIN K ANTAGONISTS IN ACUT STROKE PATIENTS WITH ATRIAL FIBRILLATION - HUNGARIAN RESULTS
    Sas Attila
    Csontos Krisztina
    Lovasz Rita
    Valikovics Attila
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (1-2): : 47 - 51
  • [43] Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation - Japan atrial fibrillation stroke trial
    Sato, H
    Ishikawa, K
    Kitabatake, A
    Ogawa, S
    Maruyama, Y
    Yokota, Y
    Fukuyama, T
    Doi, Y
    Mochizuki, S
    Izumi, T
    Takekoshi, N
    Yoshida, K
    Hiramori, K
    Origasa, H
    Uchiyama, S
    Matsumoto, M
    Yamaguchi, T
    Hori, M
    STROKE, 2006, 37 (02) : 447 - 451
  • [44] Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES Trial
    Amin, Alpesh
    Deitelzweig, Steve
    Jing, Yonghua
    Makenbaeva, Dinara
    Wiederkehr, Daniel
    Lin, Jay
    Graham, John
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (03) : 235 - 240
  • [45] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
    Connolly, S.
    Pogue, J.
    Hart, R.
    Pfeffer, M.
    Hohnloser, S.
    Chrolavicius, S.
    Yusuf, S.
    LANCET, 2006, 367 (9526): : 1903 - 1912
  • [46] Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation An indirect comparison analysis
    Blann, Andrew D.
    Skjoth, Flemming
    Rasmussen, Lars H.
    Larsen, Torben B.
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (02) : 403 - 409
  • [47] Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: Subgroup analysis of the CHARISMA randomized trial
    Hart, Robert G.
    Bhatt, Deepak L.
    Hacke, Werner
    Fox, Keith A. A.
    Hankey, Graeme J.
    Berger, Peter B.
    Hu, Tingfei
    Topol, Eric J.
    CEREBROVASCULAR DISEASES, 2008, 25 (04) : 344 - 347
  • [48] Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Goto, Shinya
    Zhu, Jun
    Liu, Lisheng
    Oh, Byung-Hee
    Wojdyla, Daniel M.
    Aylward, Philip
    Bahit, M. Cecilia
    Gersh, Bernard J.
    Hanna, Michael
    Horowitz, John
    Lopes, Renato D.
    Wallentin, Lars
    Xavier, Denis
    Alexander, John H.
    AMERICAN HEART JOURNAL, 2014, 168 (03) : 303 - 309
  • [49] Secondary stroke prevention in atrial fibrillation - Lessons from clinical practice
    Evans, A
    Perez, I
    Yu, G
    Kalra, L
    STROKE, 2000, 31 (09) : 2106 - 2111
  • [50] ASPIRIN WITH NON-VITAMIN K ANTAGONISTS VERSUS WITH VITAMIN K ANTAGONISTS FOR ATRIAL FIBRILLATION PATIENTS WITH INDICATION FOR ANTIPLATELETS: EVIDENCE FROM A META-ANALYSIS
    Nairooz, Ramez S.
    Almomani, Ahmed
    Sardar, Partha
    Ayoub, Karam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 878 - 878
12345